New research from Malawi and Zimbabwe shows integrated point-of-care testing on a multi-disease platform can improve patient care
A CHAI-supported study published in AIDS describes pilot programs in Malawi and Zimbabwe to integrate TB and HIV testing on the same near-point-of-care devices within facilities.
Read more
Statement from CHAI interim Co-CEOs Joy Phumaphi and Ann Veneman on passing of Dr. Tachi Yamada
We are deeply saddened to share the news of the passing of our Board Chair, Dr. Tachi Yamada.
Read more
Evaluating client appointment adherence under the universal test and treat strategy in Eswatini
CHAI and partners' study published in the journal of HIV Medicine looks at whether clients were less likely to keep to their appointment schedules under the Eswatini treat all policy.
Read more
Toward a generation free of hepatitis B: Why preventing infection in infants can’t wait
New approaches to ending vertical transmission of hepatitis B overlap with HIV reduction strategies.
Read more
For hep C patients who fail initial therapy, treatment is costly and often unavailable. New study shows alternative products could change that
CHAI supported an analysis, published in Clinical Infectious Diseases, identifying readily available, generic HepC treatments that have been successfully used as second-line therapy for patients in Egypt, Georgia, and Myanmar.
Read more
Innovative agreement launches affordable, optimal second-line HIV treatment in low- and middle-income countries
Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) announce pricing agreement with pharmaceutical company Hetero Labs LTD to make available generic version of best-in-class second-line therapy for people living with HIV.
Read more
CHAI sessions at IAS 2021
A full list of sessions that CHAI is participating in at the Internationl AIDS Society conference.
Read more
Girls account for 6 out of 7 new HIV infections among teens in sub-Saharan Africa. New products on the horizon could change that
CHAI presents cost-effectiveness modeling framework at IAS 2021 to understand the role of multipurpose prevention technologies in HIV prevention and family planning.
Read more
5 Questions with Asma’u Abiola
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read moreGARDP, CHAI and Shionogi announce MOU to increase access to antibiotic to treat antimicrobial resistant infections in low- and middle-income countries
Through this MOU, GARDP, CHAI and Shionogi will use their collective expertise to increase access to cefiderocol in low- and middle-income countries.
Read more